Publication | Closed Access
The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro
111
Citations
30
References
2008
Year
Hematological MalignancyNormal Human T-lymphocytesMalignant Blood DisorderImmunologyHematologyAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyCell Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1